Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 13331-23-2 | MDL No. : | MFCD00799544 |
Formula : | C4H5BO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PZJSZBJLOWMDRG-UHFFFAOYSA-N |
M.W : | 111.89 | Pubchem ID : | 2734357 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 28.53 |
TPSA : | 53.6 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.03 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | -0.07 |
Log Po/w (WLOGP) : | -1.04 |
Log Po/w (MLOGP) : | -1.76 |
Log Po/w (SILICOS-IT) : | -1.17 |
Consensus Log Po/w : | -0.81 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.89 |
Solubility : | 14.5 mg/ml ; 0.13 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.6 |
Solubility : | 27.8 mg/ml ; 0.249 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.44 |
Solubility : | 40.5 mg/ml ; 0.362 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.65 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | Stage #1: With water; sodium hydroxide In tetrahydrofuran at 23℃; for 0.333333 h; Stage #2: Aqueous phosphate buffer |
The general method for synthesizing unprotected organoboronic acids was as follows. Under ambient atmosphere, to a 100 mL flask equipped with a stir bar and charged with MIDA boronate (2) (5 mmol) as a solution in THF (50 mL) was added aqueous NaOH (1.0 M, 15 mL). The mixture was vigorously stirred for 20 min. The mixture was then transferred to a separatory funnel and was diluted with EbO (50 mL) and 0.5 M pH 7 sodium phosphate buffer (50 mL). The mixture was shaken, and the phases were separated. The aqueous phase was extracted with THFiEt2O (1 :1 , 2 x 25 mL). The combined organics were dried over MgSO4, filtered and concentrated in vacuo. Residual solvent was co-evaporated with MeCN, and the resulting solid was placed under vacuum ( ~ 1 Torr) for 30 min. All boronic acids thus obtained were judged to be > 95percent pure by 1 H-NMR and were utilized in cross-coupling reactions immediately after preparation. An example of this method is depicted in the scheme below. To form unprotected organoboronic acid 1a, the general procedure was followed using MIDA boronate 2a (1.127 g, 5.002 mmol) to yield the 1a as an off white solid (0.531 g, 95percent). TLC (EtOAc) Rf = 0.46, stained with KMnO4. 1H-NMR (500 MHz, DMSO-d6:D2O 95:5 w/ TMS) δ 7.81 (dd, / = 1 .5, 0.5 Hz, 1 H), 7.07 (dd, / = 3.0, 0.5 Hz, 1 H), 6.48 (dd, / = 3.5, 2.0 Hz, 1 H). 13C-NMR (125 MHz, DMSO-d6:D2O 95:5 w/ TMS) δ 146.4, 121.5, 1 10.3. HRMS (El +) Calculated for C4HsO3B (M) + : 1 12.0332, Found: 1 12.0332. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With C7H10N2*Pd(2+)*2Cl(1-); potassium carbonate In methanol; water for 0.166667 h; Reflux; Schlenk technique | General procedure: A 20mL Schlenk tube with a magnetic stir bar was charged with aryl halide (2mmol), arylboronic acid (2.4mmol), K2CO3 (5mmol), 10mL of solvent [H2O, H2O–MeOH (1:1), H2O–EtOH (1:1), H2O–EG (1:1)] and an aliquot of 0.01M solution of palladium complexes PdCl2(L)2 or Pd[(L)4]Cl2 in MeOH (0.001–0.2molpercent) under air atmosphere. The reaction mixture was placed in a preheated oil bath: at 100°C for MeOH–H2O, at 110°C for EtOH–H2O, at 140°C for H2O and at 160°C for EG–H2O; and stirred under reflux for the given time. After this time, the mixture was cooled, acidified by 5M HCl (in the case of acids) and diluted with 10mL of H2O and 10mL of Et2O (or EtOAc). The organic phase was separated, and the aqueous layer was extracted with Et2O EtOAc) (2×10mL). The combined organic layers were washed with H2O (10mL), brine (10mL), and dried over Na2SO4. The pure products were obtained by a simple filtration of ether solution through silica gel pad and evaporation of a solvent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | With tetrakis(triphenylphosphine) palladium(0); caesium carbonate In methanol; toluene at 100℃; for 16 h; Inert atmosphere | General procedure: According to a procedure by Oxford et al.,[3] furan-2-boronic acid (168 mg, 1.5 mmol, 1.5 eq), aryl halide (1.0 mmol, 1.0 eq), Pd(PPh3)4 (116 mg, 0.1 mmol, 10 molpercent) and cesium carbonate (350 mg, 1.1 mmol, 1.1 eq) were suspended in a toluene/MeOH mixture (4:1, 10 mL). The reaction mixture was stirred for 16 h at 100 °C. The reaction mixture was diluted with EtOAc (8 mL) and the organic layer was extracted was washed with brine (20 mL), dried over Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by flash column chromatography. |
[ 62306-79-0 ]
(5-Methylfuran-2-yl)boronic acid
Similarity: 0.84
[ 1256355-56-2 ]
(5-(Hydroxymethyl)furan-2-yl)boronic acid
Similarity: 0.77
[ 27329-70-0 ]
(5-Formylfuran-2-yl)boronic acid
Similarity: 0.74
[ 374790-93-9 ]
2-(2-Furanyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.65
[ 338998-93-9 ]
4,4,5,5-Tetramethyl-2-(5-methylfuran-2-yl)-1,3,2-dioxaborolane
Similarity: 0.60
[ 62306-79-0 ]
(5-Methylfuran-2-yl)boronic acid
Similarity: 0.84
[ 1256355-56-2 ]
(5-(Hydroxymethyl)furan-2-yl)boronic acid
Similarity: 0.77
[ 27329-70-0 ]
(5-Formylfuran-2-yl)boronic acid
Similarity: 0.74
[ 374790-93-9 ]
2-(2-Furanyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.65
[ 1150114-44-5 ]
(5-(Ethoxycarbonyl)furan-2-yl)boronic acid
Similarity: 0.60